Metraipolis › archive › dc_2ec73813e63c

Anti-MSLN chimeric antigen receptor-like NK cell therapy with tumor-penetrating capacity (uCAR-like NK) for solid tumors — Europe PMC PMID:41436559

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41436559
DOI
10.1038/s41392-[numero omesso]-0
License (as archived)
solo-consultazione
Archived
2026-11-07T11:14:42.986Z
SHA-256 of the archived text
f3f0d3888668cd77a32f2e946719ff44a9e04603ee0857e6f32ca85b6e538277
Stable URL of this page
https://metraipolis.com/documento/dc_2ec73813e63c

How to cite

Anti-MSLN chimeric antigen receptor-like NK cell therapy with tumor-penetrating capacity (uCAR-like NK) for solid tumors — Europe PMC PMID:41436559 — Europe PMC (en), https://europepmc.org/article/MED/41436559 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_2ec73813e63c (Metraipolis archive dc_2ec73813e63c, sha256 f3f0d3888668cd77a32f2e946719ff44a9e04603ee0857e6f32ca85b6e538277)
BibTeX
@misc{dc2ec73813e63c,
  title = {Anti-MSLN chimeric antigen receptor-like NK cell therapy with tumor-penetrating capacity (uCAR-like NK) for solid tumors — Europe PMC PMID:41436559},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41436559},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_2ec73813e63c; sha256 f3f0d3888668cd77a32f2e946719ff44a9e04603ee0857e6f32ca85b6e538277},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41436559. Agents can read the archived copy with the MCP tool read_document.